PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 33 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,134 | -65.3% | 5,967 | -65.4% | 0.00% | – |
| Q2 2023 | $86,723 | +161.1% | 17,241 | +219.3% | 0.00% | – |
| Q1 2023 | $33,210 | -90.1% | 5,400 | -78.7% | 0.00% | – |
| Q4 2022 | $334,541 | +334.5% | 25,344 | -1.4% | 0.00% | – |
| Q3 2022 | $77,000 | +7600.0% | 25,714 | +15390.4% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 166 | +9.2% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 152 | +3.4% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 147 | +19.5% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 123 | -0.8% | 0.00% | – |
| Q1 2021 | $1,000 | – | 124 | -0.8% | 0.00% | – |
| Q4 2020 | $0 | – | 125 | +68.9% | 0.00% | – |
| Q3 2020 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 74 | -1.3% | 0.00% | – |
| Q1 2020 | $0 | – | 75 | +3650.0% | 0.00% | – |
| Q4 2019 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |